Lantern Pharma announces plans to enhance oncology drug discovery

Lantern Pharma announces plans to enhance oncology drug discovery

Source: 
Outsourcing Pharma
snippet: 

The clinical stage biopharmaceutical company will use its RADR artificial intelligence (AI) and machine learning platform to transform the cost, pace, and timeline of oncology drug discovery and development.